USPTO serial 97431513
REGENVET
Reviewed by CopyMark Law Group
Status 731Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- KRASS,KRISTINA M
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with REGENVET?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,246*
Plus Government fees of $600
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Jersey City, NJ, US
Jersey City, NJ, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lindsay Kaplan
P.O. Box 4062Kingston, NY 12402United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and veterinary preparations, namely, solutions for application on and under tissue, bone and organ for promoting cellular regeneration, tissue adhesion, wound healing, bone or periodontium growth, and bone, organ or tissue regeneration; Adjuvants for medical purposes; Biological preparations for medical purposes, namely, platelet concentrate, platelet rich plasma, platelet poor plasma, fibrin gel, platelet rich fibrin, cell extracts, cell concentrates, stem cells, hyaluronic acid or any combinations thereof; pharmaceutical skin lotions; Tissues impregnated with pharmaceutical lotions for skin conditions, and for promoting cellular regeneration, tissue adhesion, wound healing, and regeneration of bone, organ or tissue; Medical dressings; Surgical cloth tissues; Medicated skin care preparations; Pharmaceutical products, preparations and substances for the treatment of damaged skin and tissue; Medical preparations for cleaning the skin; Cells for medical or clinical use | ACTIVE | — |
| 007 | Centrifuges for medical purposes | ACTIVE | — |
| 010 | Surgical, apparatus and instruments for medical, dental, and veterinary use; Suture materials; Medical kits comprised of surgical and medical instruments and devices, namely, blood collection tubes, drug administration tubes, syringes, needles, anticoagulants, coagulation activators in the nature of autologous thrombin serum, hyaluronic acid for pharmaceutical purposes and chitosan chemicals, gels for separating blood components, all for use in the preparation of platelet concentrate, platelet rich plasma, platelet poor plasma, fibrin gel, platelet rich fibrin, cell extracts, cell concentrates, stem cells, hyaluronic acid, chitosan or any combinations thereof; Kits for tissue and cellular regeneration, rejuvenation, healing and repair, and regenerative medicine, and for the isolation and application of platelets and cells, comprised of receptacles in the nature of blood collection tubes, drug administration tubes, sterile vials, sterile jars for holding platelet-rich plasma preparations for topical medical use, not of paper, medical syringes, needles for medical use, and disposable medical sterilization pouches; Cases fitted for medical instruments; Receptacles for applying medicines, namely, medical containers, cannula, syringes, tubes, infusion and injection devices for administering drugs, platelet rich plasma, hyaluronic acid, and hydrogels; Medical tubing for administering drugs, platelet-rich plasma, hyaluronic acid and hydrogels; Syringes for medical use; Containers specially adapted for storing tissue and biological samples for medical purposes; Surgical instruments for identifying, separating, or removing biological tissue; Medical apparatus used for taking blood; Medical apparatus for separating or filtering blood components; Medical instruments used for filtering blood and blood components; Medical apparatus for introducing pharmaceutical preparations into the human body; Surgical and medical instruments for use with biological tissues; Medical apparatus and instruments for the preparation of platelet concentrate; | ACTIVE | — |
| 044 | Veterinary services; Veterinary services, namely, hygiene and beauty treatments; Veterinary specialty services providing advanced medical, diagnostic or surgical services for animals | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by RegenLab USA LLC
- Other trademarks owned by RegenLab USA LLC
- Other trademarks in Class 005
- Other trademarks in Class 007
- Other trademarks in Class 010
- Other trademarks in Class 044
- Similar marks named REGENVET
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 30, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 30, 2026 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Sep 30, 2026 | EXT2 | SOU EXTENSION 2 FILED | — |
| Sep 30, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 28, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 27, 2026 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Mar 27, 2026 | EXT1 | SOU EXTENSION 1 FILED | — |
| Mar 27, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 30, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 5, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 5, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 30, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 26, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 26, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 26, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 26, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 26, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 17, 2025 | RDX3 | NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED | — |
| Jun 17, 2025 | RDX1 | ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED | — |
| Jun 17, 2025 | RRDX | ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED | — |
| May 9, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 9, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 9, 2025 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| May 9, 2025 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| May 9, 2025 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Feb 11, 2025 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Feb 11, 2025 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 11, 2025 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 10, 2025 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Sep 5, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 5, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 5, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 1, 2024 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jul 6, 2023 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jul 6, 2023 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jul 6, 2023 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jun 23, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 23, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 23, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 27, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 27, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 27, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 24, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 24, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 24, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 15, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 10, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 10, 2023 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Mar 10, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 10, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 2, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 31, 2022 | NWAP | NEW APPLICATION ENTERED | — |